Product details


Brinzolamide Ophthalmic suspension 1P 1% w/v
With Prescription
  • Group


  • Dosage And Administration

    When used as monotherapy or adjunctive therapy, one drop of BRINZAGAN™ in the conjunctival sac of the affected eye/s twice daily. Some patients may have better response with one drop, three times a day.

  • Each mL contains

    Brinzolamide (Sterile and micronized) IP 1% w/v
    Benzalkonium Chloride Solution (As Preservative) 0.02% w/v
    Sterile Aqueous vehicle q.s

    Indications and Usage

    BRINZAGAN™ is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

  • Active Ingredient

    Brinzolamide Ophthalmic suspension 1P 1% w/v

  • How supplied

    BRINZAGAN™ ophthalmic suspension is supplied 5 mL plastic dropper bottles.